Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03740529 |
| Title | A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Loxo Oncology, Inc. |
| Indications |
chronic lymphocytic leukemia/small lymphocytic lymphoma |
| Therapies |
Cyclophosphamide + Doxorubicin + LOXO-305 + Prednisone + Rituximab + Vincristine Sulfate |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | FRA |
CKB BOOST